|
Market Cap (13-Oct) $17,510,198 (0th) |
Close (30-Jun) $0.105 |
Volume (30-Jun) 1,951,148 |
Shortsold (16-Sep) 54,932,713 (1.27%) (225th) |
|
52w High $0.037 |
52w Low $0.004 |
P/E - |
EPS -0.02 |
[ARTICLE] Biotech CEOs hit the streets amid sector sell-off
A news article has been posted about Radiopharm Theranostics on the AFR. The article was published around , on 17 March 2022 at 5:33am.
Overseas CEOs from Chimeric Therapeutics, BCAL Diagnostics and Radiopharm Theranostics are fronting local investors, hoping to shore up support amid the sell-off.
Read ArticleRAD was $0.27 at the close of trade on 16 March 2022
Find all articles about Radiopharm Theranostics, including others on the AFR, on the media page.
You must be logged in to post a reply.